Company · CIK 0001346302
XERIS PHARMACEUTICALS INC
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/AXERIS PHARMACEUTICALS INC0001398344-22-003371 · 119.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-21-292104 · 165.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-21-292084 · 438.0 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-21-272979 · 187.4 KBSEC(opens sec.gov)
- 10-QQuarterly update0001346302-21-000076 · 8.1 MBSEC(opens sec.gov)
- 8-KCurrent report0001346302-21-000072 · 428.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-21-230205 · 190.9 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-21-227584 · 335.3 KBSEC(opens sec.gov)
- 8-KCurrent report0001346302-21-000066 · 292.9 KBSEC(opens sec.gov)
- SC 13GXERIS PHARMACEUTICALS INC0000834237-21-008770 · 12.3 KBSEC(opens sec.gov)
Insiders
- BORMANN-KENNEDY BARBARA-JEAN ANNEDirector
- DEERFIELD MANAGEMENT COMPANY, L.P.10% Owner, Possible Member of 10% Group
- Deerfield Mgmt L.P.10% Owner, Possible Member of 10% Group
- Deerfield Private Design Fund III, L.P.10% Owner, Possible Member of 10% Group
- Deutsch Barry M.See Remarks
- Edick Paul RDirector, Chief Executive Officer
- Flynn James E10% Owner, Possible Member of 10% Group
- Green Jeremy10% Owner
- HALKUFF DAWNDirector
- Hecht BethSee Remarks
Tickers
No tickers on record.
Addresses
business
180 NORTH LASALLE STREET SUITE 1600
CHICAGO, IL, 60601
mailing
180 NORTH LASALLE STREET SUITE 1600
CHICAGO, IL, 60601
Same industry